B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2

被引:28
作者
Hussein, Kais
Brakensiek, Kai
Ballmaier, Matthias
Bormann, Matthias
Goehring, Gudrun
Buhr, Thomas
Bock, Oliver
Kreipe, Hans
机构
[1] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Pediat Haematol & Oncol, D-30625 Hannover, Germany
[3] Clin Bremen Mitte, Dept Haematol & Oncol, Bremen, Germany
[4] Hannover Med Sch, Inst Cellular & Mol Pathol, D-30625 Hannover, Germany
关键词
D O I
10.1111/j.0902-4441.2006.t01-1-EJH2940.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:539 / 541
页数:3
相关论文
共 16 条
[1]   The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia [J].
Amiel, A. ;
Leopold, L. ;
Gronich, N. ;
Yukla, M. ;
Fejgin, M. D. ;
Lishner, A. .
CANCER GENETICS AND CYTOGENETICS, 2006, 167 (02) :145-149
[2]   Detection of the single hotspot mutation in the JH2 pseuclokinase domain of janus kinase 2 in bone marrow trephine biopsies derived from chronic myeloproliferative disorders [J].
Bock, O ;
Büsche, G ;
Koop, C ;
Schröter, S ;
Buhr, T ;
Kreipe, H .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (02) :170-177
[3]   CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CELL) IN THE COURSE OF POLYCYTHEMIA-VERA - DESCRIPTION OF A CASE WITH AN UNUSUAL CHROMOSOMIC ANOMALY [J].
CARULLI, G ;
MARINI, A ;
BAICCHI, U ;
SIMI, P ;
PAPINESCHI, F ;
AMBROGI, F .
TUMORI, 1987, 73 (06) :639-643
[4]  
DESOUSA AB, 1989, MED ONCOL TUMOR PHAR, V6, P239
[5]  
ISHII T, 2006, BLOOD
[6]  
JACOBSEN N, 1982, SCAND J HAEMATOL, V29, P405
[7]   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].
James, C ;
Ugo, V ;
Le Couédic, JP ;
Staerk, J ;
Delhommeau, F ;
Lacout, C ;
Garçon, L ;
Raslova, H ;
Berger, R ;
Bennaceur-Griscelli, A ;
Villeval, JL ;
Constantinescu, SN ;
Casadevall, N ;
Vainchenker, W .
NATURE, 2005, 434 (7037) :1144-1148
[8]   JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia [J].
Jelinek, J ;
Oki, Y ;
Gharibyan, V ;
Bueso-Ramos, C ;
Prchal, JT ;
Verstovsek, S ;
Beran, M ;
Estey, E ;
Kantarjian, HM ;
Issa, JPJ .
BLOOD, 2005, 106 (10) :3370-3373
[9]  
KOZA I, 1988, NEOPLASMA, V35, P77
[10]   Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders [J].
Kralovics, Robert ;
Teo, Soon-Siong ;
Li, Sai ;
Theocharides, Alexandre ;
Buser, Andreas S. ;
Tichelli, Andre ;
Skoda, Radek G. .
BLOOD, 2006, 108 (04) :1377-1380